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Mucormycosis after allogeneic haematopoietic stem cell
transplantation: a French Multicentre Cohort Study (2003–2008)
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Abstract
We conducted a nationwide retrospective study to evaluate clinical characteristics and outcome of mucormycosis among allogeneic hae-
matopoietic stem cell transplant recipients. Twenty-nine patients were diagnosed between 2003 and 2008. Mucormycosis occurred at a
median of 225 days after allogeneic haematopoietic stem cell transplant, and as a breakthrough infection in 23 cases. Twenty-six patients
were receiving steroids, mainly for graft-versus-host disease treatment, while ten had experienced a prior post-transplant invasive fungal
infection. Twenty-six patients received an antifungal treatment; surgery was performed in 12. Overall survival was 34% at 3 months and
17% at 1 year.
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